Deep Magnetic Stimulation Targeting the Medial Prefrontal and Anterior Cingulate Cortices for Methamphetamine Use Disorder: a Randomised, Double-Blind, Sham-Controlled Study
Di Zhao,Ningning Zeng,Hang-Bin Zhang,Yi Zhang,Jiatong Shan,Huichun Luo,Abraham Zangen,Ti-Fei Yuan
DOI: https://doi.org/10.1136/gpsych-2023-101149
2023-01-01
General Psychiatry
Abstract:© Author(s) (or their employer(s)) 2023. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. Craving is a key component of substance use disorders (SUDs). In recent decades, repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising treatment for individuals with SUDs by reducing their drug cravings and drugassociated cues, including methamphetamine, heroin, cocaine, nicotine and alcohol. Recently, the transdiagnostic consistency of the medial prefrontal cortex (MPFC) and anterior cingulate cortex (ACC) as neural substrates underlying cue reactivity was proposed. A recent study using highdensity, 128channel electroencephalography (EEG) reported that betaband (13–30 Hz) activity in the MPFC could serve as a neurophysiological signature for the incubation of cravings in individuals with methamphetamine use disorder (MUD). Previous neuroimaging evidence has shown that the MPFC and ACC are critical neural substrates that generate cravings in patients with MUD. Recently, the MPFC and ACC were posited as promising targets for the deep transcranial magnetic stimulation (TMS) treatment of SUD owing to their involvement in reward, emotions and habit formation. 13 However, the potential effects of rTMS to the MPFC and ACC on the cravings of patients with MUD have yet to be elucidated. Several studies on substance abuse treatment have reported the use of the H7 coil (Brainsway, Jerusalem, Israel), a TMS coil that can selectively target the MPFC and ACC. 13 In the present study, chronic rTMS was delivered via the H7 coil to the MPFC and ACC of subjects with MUD (figure 1A). We hypothesised that modulating the methamphetamine cueprocessing circuitry by targeting the MPFC might reduce cueinduced cravings and investigate the potential changes in the largescale EEG neural network and neural oscillation signature (eg, MPFC beta oscillation) of cravings that may occur in response to brain stimulation treatment. The doubleblind, shamcontrolled, randomised trial was registered at ClinicalTrials. gov (NCT04202926). In accordance with the Declaration of Helsinki, all subjects provided written informed consent and voluntarily participated in the study. The criteria for inclusion in this study are as follows: WhaT is already knoWn on This TopiC